tiprankstipranks
Uniphar PLC Reports Robust 2024 Performance and Confident 2025 Outlook
Company Announcements

Uniphar PLC Reports Robust 2024 Performance and Confident 2025 Outlook

Story Highlights

Invest with Confidence:

The latest announcement is out from Uniphar PLC ( (GB:UPR) ).

Uniphar PLC reported strong financial performance for the year ending December 2024, with an 8% growth in organic gross profit and a 12% increase in adjusted EPS. The company maintains a robust liquidity position with a net debt/EBITDA ratio of 1.5x. Looking ahead, Uniphar expects continued organic growth across all divisions in 2025 and aims to reach a medium-term EBITDA target of €200m, primarily through organic means. The company’s strategic focus on disciplined capital allocation and maintaining an active M&A pipeline underpins its growth strategy.

More about Uniphar PLC

Uniphar PLC is an international diversified healthcare services business. The company operates in the healthcare industry, providing services through its divisions: Uniphar Pharma, Uniphar Medtech, and Uniphar Supply Chain & Retail. Uniphar focuses on achieving growth through organic profit increase and strategic mergers and acquisitions.

YTD Price Performance: 4.09%

Average Trading Volume: 24,116

Technical Sentiment Consensus Rating: Buy

Current Market Cap: £480.7M

See more insights into UPR stock on TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App